Provided by Tiger Trade Technology Pte. Ltd.

Fractional Shares

2,036.19
+15.310.76%
Number of Gainers:678
Number of Losers:317
Number of Flat:25
PE:- -
High:2,041.24
Open:2,020.88
Low:2,020.88
Close:2,020.88
Volume:6.24B
Turnover:697.37B
Market Cap:97.32T
Float Cap:91.09T

Loading ...

Solana (SOLUSD) Is up 1.01% on Oct 1: What Are the Risk Factors?

TradingKey
·
Oct 01

Should CHO K1 Media Launch Require Action From Thermo Fisher Scientific Stock Investors?

Simply Wall St.
·
Oct 01

Autodesk (ADSK) Expands Arcadis AI Partnership, Is It 44% Below Fair Value?

Simply Wall St.
·
Oct 01

KKR & Co Inc : HSBC Cuts Target Price to $115 from $121

THOMSON REUTERS
·
Oct 01

Domino's Pizza Shares Leave FTSE All World Index What Investors Should Watch

Simply Wall St.
·
Oct 01

Digital Turbine, Inc. : RBC Initiates Coverage with Outperform Rating; Price Target $15

THOMSON REUTERS
·
Oct 01

Kiwoom Securities Launches 60.4 Billion Won High‑Risk Global Equity‑Linked Notes

TIPRANKS
·
Oct 01

Two Stories Ran On RH. The Harder One Was About Cash Not Growth

Simply Wall St.
·
Oct 01

Why Did Google Stock Gain in After-Hours Trading on Wednesday?

TIPRANKS
·
Oct 01

LE Minerals Sets 2026 AGM Date and Urges Investors to Update Communication Preferences

TIPRANKS
·
Oct 01

Yomiuri: Toyota Weighs Shift in Holiday Schedule

Dow Jones
·
Oct 01

Regeneron, Sanofi Expand Antibody Alliance with USD 1 Billion Upfront Payment

Reuters
·
Oct 01

Sanofi, Regeneron Expand Antibody Alliance in Long-Acting Immunology Programs for USD 1 Billion Upfront

Reuters
·
Oct 01

Elecster Names Juuso Halonen CEO Effective Dec. 1

Reuters
·
Oct 01

Sika Hosts Investor Day Highlighting Adhesive Systems Growth Strategy

Reuters
·
Oct 01

Wtw Confirms Change in Ownership of Al-Futtaim Willis

THOMSON REUTERS
·
Oct 01

WTW Takes Full Control of Al-Futtaim Willis After Al-Futtaim Sells 51% Stake

Reuters
·
Oct 01

Sanofi - Companies to Equally Share Development and Commercialization Costs, as Well as Any Future Profits

THOMSON REUTERS
·
Oct 01

Sanofi - and Regeneron Settle Prior Collaboration-Related Litigation

THOMSON REUTERS
·
Oct 01

Sanofi - Regeneron May Include Sanofi's Lunsekimig Therapy After Phase 3 Studies

THOMSON REUTERS
·
Oct 01